Is it time to tailor treatment on the basis of minimal residual disease in multiple myeloma?
Stefania Oliva
Stefania Oliva
Skip to main content We’ ve put some small files called cookies on your device to help us make improvements to our site. To improve…
To compare disease detection of myeloma using contemporary whole-body (WB) MRI and fluorine 18 ([18] F) fluorodeoxyglucose (FDG) PET/CT protocols and to correlate imaging with…
Ever heard a talk about statistics which is fun? And not just that, a talk that makes sense even if you are not good with…
Nature Reviews Drug Discovery – Discover the world’s best science and medicine | Nature.com
Listen to Blood Cancer Talks on Spotify. This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will…
Program: Oral and Poster Abstracts Type: Oral Session: 652. Multiple Myeloma: Clinical and Epidemiological: Molecular and Biological Signatures and Predictors of Outcomes Martin F. Kaiser,…
To compare disease detection of myeloma using contemporary whole-body (WB) MRI and fluorine 18 ([18] F) fluorodeoxyglucose (FDG) PET/CT protocols and to correlate imaging with…
Acknowledging the increasingly important role of whole-body MRI for directing patient care in myeloma, a multidisciplinary, international, and expert panel of radiologists, medical physicists, and…
Publisher’s Note: There is an on this article in this issue.[18] F-Fluorodeoxyglucose (FDG)–positron emission tomography (PET) and diffusion-weighted magnetic resonance imaging with background signal suppression…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…